Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody.

Literature DB >> 220285

Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody.

J C Booth, G Hannington, T A Aziz, H Stern.

Abstract

The ELISA technique has been found to be reliable for the detection and titration of cytomegalovirus-specific IgG antibody in serum. It is about six times more sensitive than the CF test although some discrepancies were found between the antibody titres determined by the two methods.

Mesh：

Substances：

Year: 1979 PMID： 220285 PMCID： PMC1145595 DOI： 10.1136/jcp.32.2.122

Source DB: PubMed Journal: J Clin Pathol ISSN： 0021-9746 Impact factor: 3.411

21 in total

1. Application of a microtechnique to viral serological investigations.

Authors: J L SEVER
Journal: J Immunol Date: 1962-03 Impact factor: 5.422

2. A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies.

Authors: P D Griffiths; K J Buie; R B Heath
Journal: J Clin Pathol Date: 1978-09 Impact factor: 3.411

3. Comparison of the enzyme-linked immunosorbent assay and the indirect hemagglutination test for detection of antibody to cytomegalovirus.

Authors: G A Castellano; G T Hazzard; D L Madden; J L Sever
Journal: J Infect Dis Date: 1977-10 Impact factor: 5.226

4. Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus.

Authors: H Schmitz; H W Doerr; D Kampa; A Vogt
Journal: J Clin Microbiol Date: 1977-06 Impact factor: 5.948

5. The characterization of IgG receptor induced by human cytomegalovirus.

Authors: S Sakuma; T Furukawa; S A Plotkin
Journal: Proc Soc Exp Biol Med Date: 1977-06

6. Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.

Authors: B Forghani; N J Schmidt; E H Lennette
Journal: Infect Immun Date: 1976-11 Impact factor: 3.441

7. Comparative activity of immunofluorescent antibody and complement-fixing antibody in cytomegalovirus infection.

Authors: R F Betts; S D George; R B Rundell; R B Freeman; R G Douglas
Journal: J Clin Microbiol Date: 1976-08 Impact factor: 5.948

8. Detection of cytomegalovirus antibody by immune adherence hemagglutination.

Authors: J L Dienstag; W L Cline; R H Purcell
Journal: Proc Soc Exp Biol Med Date: 1976-12

9. Improved glycine-extracted complement-fixing antigen for human cytomegalovirus.

Authors: J D Kettering; N J Schmidt; E H Lennette
Journal: J Clin Microbiol Date: 1977-12 Impact factor: 5.948

10. Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay.

Authors: V Knez; J A Stewart; D W Ziegler
Journal: J Immunol Date: 1976-11 Impact factor: 5.422

13 in total

1. Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Authors: D P Strachan; D Carrington; M A Mendall; B K Butland; P M Sweetnam; P C Elwood
Journal: Heart Date: 1999-03 Impact factor: 5.994

2. Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.

Authors: G R Nemerow; M F Siaw; N R Cooper
Journal: J Virol Date: 1986-05 Impact factor: 5.103

3. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.

Authors: G R Nemerow; C Mold; V K Schwend; V Tollefson; N R Cooper
Journal: J Virol Date: 1987-05 Impact factor: 5.103

4. Cytomegalovirus antigenic heterogeneity can cause false-negative results in indirect hemagglutination and complement fixation antibody assays.

Authors: R G Faix
Journal: J Clin Microbiol Date: 1985-11 Impact factor: 5.948

5. Immunity to human cytomegalovirus measured and compared by complement fixation, indirect fluorescent-antibody, indirect hemagglutination, and enzyme-linked immunosorbent assays.

Authors: J A Brandt; J D Kettering; J E Lewis
Journal: J Clin Microbiol Date: 1984-02 Impact factor: 5.948

6. Large-scale serological screening for cytomegalovirus antibodies in homosexual males by enzyme-linked immunosorbent assay.

Authors: J S Dylewski; L Rasmussen; J Mills; T C Merigan
Journal: J Clin Microbiol Date: 1984-02 Impact factor: 5.948

7. Viral antibody screening system that uses a standardized single dilution immunoglobulin G enzyme immunoassay with multiple antigens.

Authors: J Blomberg; I Nilsson; M Andersson
Journal: J Clin Microbiol Date: 1983-06 Impact factor: 5.948

8. Normalized enzyme-linked immunosorbent assay for determining immunoglobulin G antibodies to cytomegalovirus.

Authors: D J Kiefer; D A Phelps; S P Halbert
Journal: J Clin Microbiol Date: 1983-07 Impact factor: 5.948

9. Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody.

Authors: J C Booth; G Hannington; T M Bakir; H Stern; H Kangro; P D Griffiths; R B Heath
Journal: J Clin Pathol Date: 1982-12 Impact factor: 3.411

10. Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus.

Authors: R V Krishna; O H Meurman; T Ziegler; U H Krech
Journal: J Clin Microbiol Date: 1980-07 Impact factor: 5.948